TMCnet News
ACCELERATE SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Accelerate Diagnostics, Inc.Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) violated state or federal laws. On March 9, 2015, Citron Research issued a report titled "AXDX: a Near-Billion Valuation Whose Big Lie was Just Exposed by the SEC (News - Alert)". In this article, Citron remarks on the inaccuracy of claims by Accelerate Diagnostics that its ID/AST technology identifies blood pathogens and antibiotic sensitivities without requiring a positive blood culture. Accelerate Diagnostics received challenging comments about this "culture free" claim from the Securities and Exchange Commission's staff with respect to the company's Form 10-K for the fiscal year ended December 31, 2013. Citron's article states that "the SEC's challenges expose the company's utter disregard for truthful disclosure to its own shareholders" regarding ID/AST technology and the need for blood cultures. Additionally Citron states, "the SEC publicly takes note that since 2004, AXDX has claimed to its invetors that their ID/AST technology diagnoses blood pathogens and identifies antibiotic sensitivities without requiring a positive blood culture. Such capability, if true, would be a tremendous clinical improvement on existing methodologies, delivering 'accelerated' diagnostic and antibiotic sensitivity results in hours, rather than days in the case of serious and life threatening blood-borne infections. If after all these years, the ID/AST platform still needs a prerequisite positive blood culture before running diagnostic testing on its platform, it is Citron's opinion that the company's technology is worthless in the 2015 diagnostic landscape". Johnson & Weaver's investigation will seek to determine whether shareholders were harmed by fraud and deception as Citron claims. If you have information that could assist in this investigation, or if you are an Accelerate Diagnostics shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) by email or by phone at 619-814-4471. About Johnson & Weaver, LLP: Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
|
